Equity
Equity Analysis
Price
 Gainers & Losers
 Weekly Gainers & Losers
 Monthly Gainers & Losers
 Out & Under Performers
 Advances & Declines
 New Highs & Lows
 52 Week Highs & Lows
 Weightage
 Only Buyers & Sellers
 Historical Returns
Volume
Analysis
Exchange Holidays
News Analysis
Corporate Action
Corporate Info
Other Market
  Home   >  CORPORATE ACTION  > Board Meetings
Board   Meetings      
As On Mar 30,2026
Options:
Asston Pharma  
Inter alia, to consider and approve the following matters: 1. To c ........
Bazel International  
Increase in Authorised Capital
Classic Leasing &Fin  
Inter-alia, to consider the following matters: a) Resignation of M ........
DAR Credit & Capital  
Fund Raising
Davangere Sugar Co  
Inter alia, to consider and approve:- Raising of funds, in one or ........
Ducon Infra.  
Inter alia, to consider and approveappointment of Director/KMPs if ........
Earkart  
Inter-alia to consider and approve the following agenda: a. Varia ........
Flomic Global Logist  
Inter alia, to consider and transact the following businesses: 1. ........
Ganesh Consumer Prod  
Inter alia to Consider and approve the appointment of Internal Audi ........
Garware Hi-Tech  
Inter alia, to consider and approve the Annual Business / Operation ........
GS Auto Intl.  
Inter alia, to consider and approve the following proposal: 1. To ........
Jash Engineering  
Interim Dividend
John Cockerill India  
Inter alia, to consider and approve:- 1. To fix the day, date, tim ........
Manappuram Finance  
Inter alia, to consider and approve:- the borrowing program includ ........
Methodhub Software  
Inter alia, for obtaining the approval to acquire 100 % shareholdin ........
MIC Electronics  
Preferential Issue of shares & Inter alia, to consider and, if thoug ........
Mono Pharmacare  
Other business matters
Nazara Technologies  
Preferential Issue of shares & Inter-alia, to transact the following ........
PFL Infotech  
Reduction of Capital & Inter alia, to consider and approve:- 1) To ........
Simran Farms  
Inter alia, to transact following businesses: - 1. To consider and ........
Supha Pharmachem  
Quarterly Results
Swarnsarita Jewels  
Independent Director Meeting
Ushakiran Finance  
Inter alia, to consider, review and approve the general business o ........
Veer Global Infracon  
Inter alia, to consider and approve the following: 1. To consider ........
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.